Inventor · disambiguated record
Jae Du Ha
Also filed as: HA JAE D · HA JAE DU
10 granted patents·6 pending applications·69 citations·filing 1993–2024
86Inventor score
Top patents by PatentIndex Score
16 records- 0192US9199944B2N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancerKOREA RES INST CHEM TECH·Filed 2015·Granted Dec 1, 2015·10 cites·11 claims
- 0291US8754209B2Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredientSIM TAE BO·Filed 2009·Granted Jun 17, 2014·30 cites·8 claims
- 0388US9403831B2Triazolopyrazine derivative and use thereofKOREA RES INST CHEMICAL TECH·Filed 2013·Granted Aug 2, 2016·14 cites·16 claims
- 0479US11192878B2Piperidine-2,6-dione derivative and use thereofKOREA RES INST CHEMICAL TECH·Filed 2018·Granted Dec 7, 2021·3 cites·5 claims
- 0577US11084824B2Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredientKOREA RES INST CHEMICAL TECH·Filed 2018·Granted Aug 10, 2021·2 cites·6 claims
- 0675US2025082762A1Novel bifunctional heterocyclic compound having btk degradation function via ubiquitin proteasome pathway, and use thereofKOREA RES INST CHEMICAL TECH·Filed 2024·Application pending·0 cites
- 0775US2025073341A1Bifunctional heterocyclic compound having btk degradation function via ubiquitin proteasome pathway, and use thereofKOREA RES INST CHEMICAL TECH·Filed 2024·Application pending·0 cites
- 0867US12161722B2Bifunctional heterocyclic compound having BTK degradation function via ubiquitin proteasome pathway, and use thereofKOREA RES INST CHEMICAL TECH·Filed 2022·Granted Dec 10, 2024·0 cites·2 claims
- 0963US10053458B2Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredientKOREA RES INST CHEMICAL TECH·Filed 2015·Granted Aug 21, 2018·1 cites·10 claims
- 1062US5409933AQuinoline derivatives and processes for preparing the sameFiled 1993·Granted Apr 25, 1995·9 cites·5 claims
- 1160US2025346575A1Isoindolinone derivative having glutarimide mother nucleus, and use thereofKOREA RES INST CHEMICAL TECH·Filed 2022·Application pending·0 cites
- 1255US2024252488A1Mlkl binding or degrading compound and pharmaceutical use thereofKOREA RES INST CHEMICAL TECH·Filed 2021·Application pending·0 cites
- 1351US2024018123A1Compound for inhibiting or disintegrating androgen receptor, and pharmaceutical use thereofKOREA RES INST CHEMICAL TECH·Filed 2021·Application pending·0 cites
- 1448US2022105188A1Target protein eed degradation-inducing degraducer, preparation method thereof, and pharmaceutical composition for preventing or treating diseases related to eed, ezh2, or prc2, comprising same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2020·Application pending·0 cites
- 1535US10369149B24-(2-amino-tetrahydronaphthalenyl)pyrimidine derivative, preparation method therefor, and pharmaceutical composition for preventing or treating cancer, containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2015·Granted Aug 6, 2019·0 cites·9 claims
- 1635US10100019B2N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2016·Granted Oct 16, 2018·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Jae Du Ha files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →